AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 APR 11 - (NewsRx.com & NewsRx.net) -- Women with high levels of serum lipoprotein (high-density lipoprotein and low-density lipoprotein [LDL]) and no dementia are at higher risk of developing cognitive impairment than women who have lower lipoprotein levels and who are on statin drugs, according to an article in the March 14, 2002, issue of the Archives of Neurology.
Kristine Yaffe, MD, from the University of California, San Francisco, and colleagues studied 1037 postmenopausal women younger than 80 years with established coronary disease from the Heart Estrogen/progestin Replacement Study Trial. None of the women had a history of dementia at enrollment. Participants were randomly assigned to treatment with daily oral estrogens or placebo.
The Modified Mini-Mental State Examination (3MS, a brief cognitive test) was administered at the end of the 4-year trial.
"High LDL and total cholesterol levels are associated with cognitive impairment," the authors stated. "Lowering these lipoprotein levels may be a strategy for preventing impairment."
In background information in the article, the authors noted that few modifiable risk factors for cognitive impairment have been identified. Certain studies, according to the authors, suggest that high total cholesterol levels ...